179 related articles for article (PubMed ID: 9397948)
1. Phorbol 12-myristate 13-acetate and 1,25-dihydroxyvitamin D3 regulate 1,25-dihydroxyvitamin D3 receptors synergistically in rat osteosarcoma cells.
Reinhardt TA; Horst RL
Mol Cell Endocrinol; 1994 May; 101(1-2):159-65. PubMed ID: 9397948
[TBL] [Abstract][Full Text] [Related]
2. Bidirectional regulation of the 1,25-dihydroxyvitamin D3 receptor by phorbol ester-activated protein kinase-C in osteoblast-like cells: interaction with adenosine 3',5'-monophosphate-induced up-regulation of the 1,25-dihydroxyvitamin D3 receptor.
van Leeuwen JP; Birkenhäger JC; Buurman CJ; van den Bemd GJ; Bos MP; Pols HA
Endocrinology; 1992 Apr; 130(4):2259-66. PubMed ID: 1312452
[TBL] [Abstract][Full Text] [Related]
3. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the functional involvement of protein kinase C in the action of 1,25-dihydroxyvitamin D3 in bone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GJ; Buurman CJ; Staal A; Bos MP; Pols HA
J Biol Chem; 1992 Jun; 267(18):12562-9. PubMed ID: 1320001
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of inducible nitric oxide (NO) synthase and NO production in HL-60 cells stimulated to differentiate by phorbol 12-myristate 13-acetate plus 1,25-dihydroxyvitamin D3 is not obtained with dimethylsulfoxide plus 1,25-dihydroxyvitamin D3.
Kawase T; Orikasa M; Oguro A; Burns DM
Calcif Tissue Int; 1998 Jul; 63(1):27-35. PubMed ID: 9632843
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells.
Klaus G; von Eichel B; May T; Hügel U; Mayer H; Ritz E; Mehls O
Endocrinology; 1994 Oct; 135(4):1307-15. PubMed ID: 7523093
[TBL] [Abstract][Full Text] [Related]
8. Modulation of parathyroid hormone-sensitive adenylate cyclase in ROS 17/2.8 cells by dexamethasone 1,25-dihydroxyvitamin D3 and protein kinase C.
Rao LG; Wylie JN
Bone Miner; 1993 Oct; 23(1):35-47. PubMed ID: 8274878
[TBL] [Abstract][Full Text] [Related]
9. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 and phorbol myristate acetate produce divergent phenotypes in a monomyelocytic cell line.
Biskobing DM; Rubin J
Endocrinology; 1993 Feb; 132(2):862-6. PubMed ID: 8425498
[TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine 3',5'-monophosphate up-regulates 1,25-dihydroxyvitamin D3 receptor gene expression and enhances hormone action.
Krishnan AV; Feldman D
Mol Endocrinol; 1992 Feb; 6(2):198-206. PubMed ID: 1314957
[TBL] [Abstract][Full Text] [Related]
12. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
Musiol IM; Feldman D
Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3.
Arbour NC; Prahl JM; DeLuca HF
Mol Endocrinol; 1993 Oct; 7(10):1307-12. PubMed ID: 8264662
[TBL] [Abstract][Full Text] [Related]
14. 17 beta-estradiol increases the receptor number and modulates the action of 1,25-dihydroxyvitamin D3 in human osteosarcoma-derived osteoblast-like cells.
Ishibe M; Nojima T; Ishibashi T; Koda T; Kaneda K; Rosier RN; Puzas JE
Calcif Tissue Int; 1995 Dec; 57(6):430-5. PubMed ID: 8581875
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 and 12-O-tetradecanoyl phorbol 13-acetate cause differential activation of Ca(2+)-dependent and Ca(2+)-independent isoforms of protein kinase C in rat colonocytes.
Bissonnette M; Wali RK; Hartmann SC; Niedziela SM; Roy HK; Tien XY; Sitrin MD; Brasitus TA
J Clin Invest; 1995 May; 95(5):2215-21. PubMed ID: 7738187
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 and macrophage colony-stimulating factor-1 synergistically phosphorylate talin.
Meenakshi T; Ross FP; Martin J; Teitelbaum SL
J Cell Biochem; 1993 Oct; 53(2):145-55. PubMed ID: 8227187
[TBL] [Abstract][Full Text] [Related]
18. Involvement of protein kinase C in the modulation of 1alpha,25-dihydroxy-vitamin D3-induced 45Ca2+ uptake in rat and chick cultured myoblasts.
Vazquez G; de Boland AR
Biochim Biophys Acta; 1996 Jan; 1310(1):157-62. PubMed ID: 9244190
[TBL] [Abstract][Full Text] [Related]
19. Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3.
Van Auken M; Buckley D; Ray R; Holick MF; Baran DT
J Cell Biochem; 1996 Dec; 63(3):302-10. PubMed ID: 8913881
[TBL] [Abstract][Full Text] [Related]
20. Synergistic enhancement by 12-O-tetradecanoylphorbol-13-acetate and dibutyryl cAMP of 1alpha,25-dihydroxyvitamin D3 action in human promyelocytic leukemic HL-60 cells.
Hiura Y; Inaba M; Nishizawa Y; Otani S; Morii H
Endocr J; 1999 Apr; 46(2):317-24. PubMed ID: 10460017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
